Viewing nowCirtan Tablets 80 mg (Valsartan)
Valsartan 80mg
Tablet · Prescription medication
H LB Pharmaceuticals Co., Ltd.

MFDS item code 200809259 · Notified 2008.09.05 · Insurance code 647301560
Treatment of essential hypertension and heart failure; reduction in the risk of death after myocardial infarction
This medication is primarily used to treat hypertension (essential hypertension) and heart failure. It is particularly suitable for heart failure patients who are intolerant to ACE inhibitors and helps reduce the mortality risk in myocardial infarction patients confirmed to have left ventricular dysfunction by symptoms or test results. It plays an important role in managing cardiovascular health with these efficacies and is used safely to control blood pressure and improve heart function.
1. Essential hypertension Take with water during a meal or between meals. It is recommended to take the medicine at the same time each day (e.g., in the morning), if possible. 1) Adults: The recommended dose is 80 mg of valsartan orally once daily, regardless of sex or race. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg daily or a diuretic may be coadministered. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 320 mg daily. 2) Elderly patients (aged 75 years and older): Initiate treatment with 40 mg of this medicine once daily. 3) Patients with renal impairment: (1) Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is necessary. (2) Creatinine clearance 10 ∼ 20 mL/min: Initiate treatment with 40 mg of this medicine once daily. (3) Creatinine clearance below 10 mL/min and patients on dialysis: Do not administer this medicine. 4) Patients with volume depletion: In patients with volume depletion (e.g., patients taking high doses of diuretics whose dose cannot be reduced), initiate treatment with 40 mg of this medicine once daily. 5) Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, initiate treatment with 40 mg of this medicine once daily; do not exceed 80 mg daily. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure Adults: The recommended starting dose is 40 mg of this medicine orally twice daily. The dose may be increased to 80 mg or 160 mg per dose. When administered concomitantly with a diuretic, consider reducing the diuretic dose. The maximum daily dose is 320 mg, administered in divided doses. Triple combination therapy with this medicine, an ACE inhibitor, and a beta-blocker is not recommended. 3. Reduction of the risk of death after myocardial infarction Adults: Treatment may be initiated within 12 hours of the onset of myocardial infarction. The recommended starting dose is 20 mg of this medicine twice daily. Thereafter, over several weeks, increase the dose as tolerated by the patient to 40 mg, 80 mg, and 160 mg per dose, administered twice daily. Consider dose reduction if symptoms of hypotension or renal failure occur. This medicine may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytic agents, acetylsalicylic acid, beta-blockers, and statins). However, concomitant use with an ACE inhibitor is not recommended. 4. Patients with renal impairment: No dose adjustment is necessary when creatinine clearance is 10 mL/min or higher. However, do not administer this medicine to patients with creatinine clearance below 10 mL/min or to patients on dialysis, as there is no experience with its use in these patients. 5. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, it is preferable not to exceed a daily dose of 80 mg. If administering 80 mg or more daily, consider whether the benefits of dose escalation outweigh the risks. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis.
The safety and efficacy of this medicine have not been established in children and adolescents under 18 years of age.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Persons with allergies to this drug or its components, women who are pregnant or may become pregnant, nursing mothers, and those with severe liver or kidney diseases should not take this medication. Elderly patients or those with high serum potassium levels, patients with impaired liver function, and patients with heart valve disease or cardiovascular diseases must consult a physician before taking this medication. Taking this medication may cause side effects such as headache, dizziness, fatigue, cough, and diarrhea, and serious side effects like blood pressure drop or abnormal kidney function may occur, so caution is necessary. In the initial period of treatment, blood pressure may drop sharply, so patients on dialysis or those taking diuretics should start with a low dose and be closely monitored for their condition. Patients with renal vascular issues may experience worsening kidney function while on this medication, thus requiring careful monitoring. This drug may raise serum potassium levels, and when taken with potassium supplements or potassium-sparing diuretics, serum potassium concentration should be monitored closely. There may be interactions when taken with other blood pressure medications, diuretics, or non-steroidal anti-inflammatory drugs (NSAIDs), so inform your physician or pharmacist of any other medications being taken. Dizziness or drowsiness may occur when driving or operating machinery, so caution is advised. Women who are pregnant or breastfeeding are advised against taking this medication, and if unavoidable, should do so only after consulting a professional. Overdose may result in severe hypotension or altered consciousness, so follow the prescribed dosage accurately and contact a healthcare facility immediately if any abnormal symptoms appear. Safety has not been established in children and adolescents, and it is recommended that individuals under 18 years of age do not use this medication. Store this medication out of reach of children and do not transfer it to another container.
headache
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air and moisture exposure and should be kept in a cool place below 30 degrees Celsius, avoiding direct sunlight or high temperatures. Proper storage helps to maintain the efficacy of the medication for an extended period.
Light pink, biconvex, round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowValsartan 80mg
Tablet · Prescription medication
H LB Pharmaceuticals Co., Ltd.

Valsartan 80mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 160mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 40mg
Tablet · Prescription medication
Samsung Novartis Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan 320mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.